As of June 30, 2023, Mithra Pharmaceuticals S.A. has 58.59M shares outstanding.
| Shares Outstanding | 58.59M |
As of June 30, 2023, Mithra Pharmaceuticals S.A. maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.04 |
| Quick Ratio | 0.27 |
| Debt / Equity | -2,379.86 |
As of June 30, 2023, Mithra Pharmaceuticals S.A. has an Altman Z-Score of -2.77, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -2.77 |
Already premium?